What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients

In vitro cell therapy also indicated that infusion of Treg cells could increase the expression of anti-inflammatory factors (such as IL-10, IL-4, TGF-, IL-2), while reducing the levels of pro-inflammatory factors (such as IL-17, IFN-) (94)
Severe redness, itching, swelling, or blistering signal issues beyond regular purging and need immediate attention
These may include arguing that the plaintiff should be barred from recovery or receive a lesser amount of compensation due to assumption of the risk, misuse of the product, or comparative fault